July 19, 2022 Comments Off on New patent expiration for Novartis drug LEQVIO Posted in: Uncategorized
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are nineteen patents protecting…
The post New patent expiration for Novartis drug LEQVIO appeared first…
July 19, 2022 Comments Off on New patent expiration for Provensis drug VARITHENA Posted in: Uncategorized
Annual Drug Patent Expirations for VARITHENA Varithena is a drug marketed by Provensis and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent expiration for Provensis drug VARITHENA appeare…
